News & Media

Archives

Cardinal Health acquires Mirixa Corporation
Expanded portfolio brings payers an enhanced pharmacy services network.

DUBLIN, Ohio, January 8, 2019 — Cardinal Health, Inc. announced today it has acquired Mirixa Corporation, a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA). The business will integrate into OutcomesMTM, a pioneer in the MTM market, at Cardinal Health.

This expanded portfolio from Cardinal Health will bring payers an enhanced pharmacy services network and will standardize care delivery, documentation and billing for MTM services.

“For many years, OutcomesMTM and Mirixa have shared a common vision to increase healthcare quality and decrease cost through the appropriate use of medication,” said Tom Halterman, vice president of Medication Therapy Management Solutions at Cardinal Health and founder of OutcomesMTM. “We are excited about this opportunity to unite these two companies and continue to advance this shared vision under the Cardinal Health umbrella.”

Merging the technology platforms deployed by Mirixa and OutcomesMTM is an important priority of the transaction. In addition, this combination simplifies the workflow for pharmacy staffs in retail, clinic and long-term care settings, allowing them to more effectively deliver services to patients.

“When the integration is complete, pharmacists will no longer need to sign in to multiple portals to navigate their MTM opportunities,” added Halterman. “A single, standardized platform will enable any health plan to connect their members with over 100,000 US pharmacists.”

Through the platform, clinical services such as comprehensive medication reviews, medication adherence consultations and other important interventions can be deployed.

“The original objective of Mirixa was to empower and enable independent community pharmacists, which is a vision this integration with OutcomesMTM and Cardinal Health seeks to continue,” said B. Douglas Hoey, pharmacist, MBA and CEO of NCPA. “In addition to benefiting pharmacists, who can work more closely with patients and be reimbursed for high-touch care, MTM services also result in increased adherence to medications. That increased adherence saves money for health plans, employers and taxpayers in the form of reduced healthcare costs overall.”

Terms of the transaction were not disclosed.

To learn more, visit www.outcomesmtm.com.

 

About Cardinal Health 

Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products, pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. To help combat prescription drug abuse, the company and its education partners created Generation Rx, a national drug education and awareness program. Backed by nearly 100 years of experience, with approximately 50,000 employees in nearly 46 countries, Cardinal Health ranks #14 on the Fortune 500. For more information, visit cardinalhealth.com, follow @CardinalHealth on Twitter, @cardinalhealthwings on Facebook and connect on LinkedIn at linkedin.com/ company/cardinal-health.

 

About the National Community Pharmacists Association

Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing 22,000 pharmacies that employ 250,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit www.ncpanet.org.


Get news alerts by email

Complete the form below to receive e-mail notifications of our news releases. You will receive an email which you must reply to in order to confirm your subscription. You may unsubscribe from our list at anytime.